We are delighted to announce that UK Patent number GB 2597968 has been granted for the technology that drives Airshield.
Airshield is a unique capture-at-source air protection device that creates a downward moving flow of laminar air, to catch and remove the aerosols that could otherwise carry the Covid virus and other pathogens from person to person when they meet.
The efficacy of Airshield has been independently tested by the Medical Technologies Innovation Facility at Nottingham Trent University, which demonstrated that Airshield catches 99% of the aerosols that can carry the virus from person to person when meeting, giving substantially better protection than a surgical mask, visor or plastic screen.
Airshield will protect vulnerable professionals like doctors and pharmacists from becoming super-spreaders of viruses and allow these critical areas to continue without risk of becoming centres of transmission.
